---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-089929"
form_type: "8-K"
ticker: "COR"
cik: "0001140859"
company_name: "Cencora, Inc."
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T08:57:27.636027+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Cencora elects Frank Clyburn to its board of directors, effective Oct 1, 2024

## Summary
- Frank Clyburn appointed as independent director, effective October 1, 2024.
- Board will increase from 11 to 13 members as a result.
- Clyburn previously CEO of IFF and EVP at Merck; brings pharmaceutical industry expertise.
- Compensation follows non-employee director policy, pro-rated until 2025 annual meeting.

## SEC filing metadata
- accession: 0001104659-24-089929
- form_type: 8-K
- ticker: COR
- cik: 0001140859
- company_name: Cencora, Inc.
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1140859/000110465924089929/0001104659-24-089929-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1140859/000110465924089929/tm2421656d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-089929
- JSON: https://secwatch.observer/filing/0001104659-24-089929.json
- Plain text: https://secwatch.observer/filing/0001104659-24-089929.txt

## Key facts
- Executive change
  Frank Clyburn was appointed as Director at Cencora, Inc..
  - Action: appointed
  - Role: Director
  source text: On August 13, 2024, the Board of Directors (the "Board") of Cencora, Inc. (the "Company") appointed Frank Clyburn to serve on the Board (the "Appointment"), with such Appointment to be effective as of October 1, 2024 (the "Effective Date").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1140859/000110465924089929/0001104659-24-089929-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.